+Search query
-Structure paper
Title | Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 60, Page 7677-7702, Year 2017 |
Publish date | May 3, 2017 (structure data deposition date) |
Authors | Mikami, S. / Nakamura, S. / Ashizawa, T. / Nomura, I. / Kawasaki, M. / Sasaki, S. / Oki, H. / Kokubo, H. / Hoffman, I.D. / Zou, H. ...Mikami, S. / Nakamura, S. / Ashizawa, T. / Nomura, I. / Kawasaki, M. / Sasaki, S. / Oki, H. / Kokubo, H. / Hoffman, I.D. / Zou, H. / Uchiyama, N. / Nakashima, K. / Kamiguchi, N. / Imada, H. / Suzuki, N. / Iwashita, H. / Taniguchi, T. |
External links | J. Med. Chem. / PubMed:28796496 |
Methods | X-ray diffraction |
Resolution | 2.2 Å |
Structure data | PDB-5vp0: |
Chemicals | ChemComp-ZN: ChemComp-MG: ChemComp-9GJ: ChemComp-HOH: |
Source |
|
Keywords | HYDROLASE/HYDROLASE INHIBITOR / Inhibitor / Phosphodiesterase / Brain-Pentrating / Cognitive Disorders / HYDROLASE-HYDROLASE INHIBITOR complex |